Skip to main content
IC
Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
20.94
-0.60 (-2.79%)
At close: May 13, 2025, 4:00 PM
20.27
-0.67 (-3.18%)
Pre-market: May 14, 2025, 8:57 AM EDT

Travere Therapeutics Revenue

Travere Therapeutics had revenue of $81.73M in the quarter ending March 31, 2025, with 97.54% growth. This brings the company's revenue in the last twelve months to $273.53M, up 75.65% year-over-year. In the year 2024, Travere Therapeutics had annual revenue of $233.18M with 60.55% growth.

Revenue (ttm)
$273.53M
Revenue Growth
+75.65%
P/S Ratio
6.25
Revenue / Employee
$710,475
Employees
385
Market Cap
1.86B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024233.18M87.94M60.55%
Dec 31, 2023145.24M35.78M32.69%
Dec 31, 2022109.46M-22.38M-16.97%
Dec 31, 2021131.84M-66.49M-33.52%
Dec 31, 2020198.32M22.98M13.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

TVTX News

More News